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The activities of rat brain protein kinase C isoenzymic fractions separated byhydroxyapatite chromatography were mea- 
sured with histone HI or the oligopeptide Ala-Ala-Ala-Ser-Phe-Lys-Ala-Lys-Lys-amide s substrates. The oligopeptide 
was a better substrate han histone HI for nearly all of the protein kinase C fractions. Two subfractions of type III iso- 
enzyme were resolved (llIa and IIIb); type IIIb was characterized by a very low histone kinase activity compared toits 
peptide kinase activity. In some brain extracts a phospholipid-dependent but Ca2+-inhibited protein kinase was also ob- 
served which was eluted from the hydroxyapatite column between type II and III isoenzymes of protein kinase C. 
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1. INTRODUCTION 
Protein kinase C (PKC) is known to be a family 
of proteins which are closely related to but distinct 
from one another. The different isoenzymes have 
distinct functions in the regulation of cellular 
responses to extracellular stimuli. The initial 
analysis of mammalian brain cDNA libraries has 
revealed four subspecies (O(,]~I~II,7) and recently 
three additional members of the family (d,e,~') have 
been isolated from a rat brain cDNA library 
(reviewed in [1]). 
On the other hand three major types of protein 
kinase C isoenzymes have been resolved by 
hydroxyapatite chromatography of protein kinase 
C preparations purified from brain [2-4] and the 
correspondence of type I, I I  and II I  isoenzymes to 
the cDNA designated 7, fll +f?xI and a, respective- 
ly, has been determined [5]. These subspecies are 
differentially distributed in various tissues 
Correspondence address: A. Farag6, 1st Institute of 
Biochemistry, Semmelweis University Medical School, PO Box 
260, 1444 Budapest 8, Hungary 
[1,3,6--9], type I protein kinase C has been found 
exclusively in the central nervous ystem while type 
II or type II I  or both isoenzymic fractions have 
been detected in the extracts of a series of tissues 
and cells [8-12]. However, rat lung and heart [9] 
and human platelets [10] have been reported to 
contain isoenzymes distinct from type II or type 
I I I ,  three isoenzymic fractions have been separated 
from the livers of different species [13] and four 
isoenzymic fractions have been resolved in a pro- 
tein kinase C preparation purified from rat brain 
[14]. In these experiments the activity of protein 
kinase C has been detected with H1 histone as a 
substrate. 
The characterisation f the PKC isoenzyme n- 
coded by the e gene has also been attempted 
[15-17]. A murine PKC-e subtype has been ex- 
pressed in COS-1 cells which has unique substrate 
specificity and its activity is independent from 
Ca 2+. This PKC-e isoenzyme does not phospho- 
rylate H1 histone but phosphorylates a synthetic 
peptide designated as pep-e [17]. 
Previously we synthesized an oligopeptide which 
proved to be a specific substrate for PKC [18-21]. 
Published by Elsevier Science Publishers B.V. (Biomedical Division) 
324 00145793/89/$3.50 © 1989 Federation of European Biochemical Societies 
Volume 249, number 2 FEBS LETTERS June 1989 
This peptide contains specificity determinants 
which share some properties with pep-e. With the 
aid of this oligopeptide substrate we demonstrate 
two functional ly different subfractions of type II I  
PKC and a phosphol ipid-dependent bu  Ca2+-in - 
hibited protein kinase in the extract of rat brain. 
0.01 mM [.Z-32p]ATP (250000-300000 cpm per reaction mix- 
ture), 0.7 mg/ml of the synthetic peptide Ala-Ala-Ala-Ser-Phe- 
Lys-Ala-Lys-Lys-amide or 1 mg/ml of histone H1 and 
50-100-#l samples of the enzyme fractions. Radioactivity incor- 
porated into the oligopeptide substrate was measured as 
described in [19] and the same method used for measuring the 
radioactivity incorporated into histone H1. 
2. EXPERIMENTAL  
2.1. Fractionation of protein kinase C isoenzymes by 
hydroxyapatite high performance chromatography 
Extracts were prepared from whole brains. One rat brain was 
homogenized in 10 ml of a solution comprising 1mM EGTA, 
2 mM phenylmethylsulphonyl fluoride (PMSF), 0.02% leupep- 
tin, 40 mM KCI and 20 mM Tris-HC1 (pH 7.5). The suspension 
was centrifuged at100000 x g for 30 min. The supernatant was 
diluted with 5 mM potassium phosphate (pH 7.5) containing 
2 mM PMSF to a final volume of 45 ml. Rabbit brain extract 
was prepared by the same method from half of a rabbit brain. 
A 9 ml sample was filtered on a membrane (Sartorius 11307) 
and applied immediately to a Bio-Gel HPHT column (7.8 x 
100 mm) connected toan HPLC system (DuPont 850). The col- 
umn was washed with 10 mM potassium phosphate (pH 7.5) 
and elution performed with a concentration gradient of 
potassium phosphate (pH 7.5) from 10 to 200 mM. The flow 
rate was 0.75 ml per min, with 0.4-ml samples being collected 
and the slope of the gradient being varied in the different ex- 
periments as indicated. 
2.2. Fractionation of protein kinase C isoenzymes by phenyl- 
Sepharose chromatography 
Two rat brains were homogenized in 20 ml of a solution con- 
taining 250 mM sucrose, 40 mM KC1, 20 mM Tris-HC1 (pH 
7.5), 10 mM EGTA, 2 mM EDTA, 2 mM PMSF, 0.02% 
leupeptin, 1 mM dithioerythritol (DTE) and 10 -5 M cAMP. 
The suspension was centrifuged for 30 min at 40000 x g. The 
supernatant was diluted with 5 mM potassium phosphate (pH 
7.5) (containing 2 mM EGTA, 1 mM EDTA and 1 mM DTE) 
to a final volume of 40 ml and applied to a DEAE-Sephacel col- 
umn (20 x 50 mm). The column was washed and protein kinase 
C eluted with a linear concentration gradient of potassium 
phosphate (pH 7.5) containing 1 mM EGTA, 1 mM EDTA and 
1 mM DTE. 4.5-ml fractions were collected. The top fractions 
of the PKC peak were combined and samples analyzed by 
hydroxyapatite chromatography or phenyl-Sepharose chroma- 
tography. For the latter, a sample of the combined fractions 
was completed with addition of potassium phosphate (pH 7.5) 
to 0.75 M (final concentration) and applied immediately to a 
phenyl-Sepharose column (10 x 30 mm). The column was 
washed with 0.75 M potassium phosphate and elution of PKC 
fractions performed with a decreasing concentration gradient of 
potassium phosphate from 0.75 to 0.005 M (containing 1mM 
EGTA, l mM EDTA, 1 mM DTE). Finally, the column was 
washed with 0.0005 M potassium phosphate. 4 5-ml fractions 
were collected. 
2.3. Assay of protein kinase C activity 
Assays (at 37°C for 10 min) were carried out in 200 #l of a 
mixture comprising 50 mM Tris-HCl (pH 7.5), 10 mM MgC12, 
3. RESULTS AND DISCUSSION 
Protein kinase C isoenzymes were fractionated 
by hydroxyapatite high performance chromatog- 
raphy from cytosolic extracts of rat brain, the en- 
zyme activity being detected with the synthetic 
peptide substrate. Although type I and II enzymes 
were eluted as a single peak, type III PKC was well 
separated and appeared to be composed of a minor 
and a major  fraction. The crude cytosolic extract 
of rabbit  brain showed a similar chromatographic 
pattern (fig.l). Previously, we demonstrated a 
phosphol ipid-dependent bu Ca2+-inhibited pro- 
tein kinase fraction in extracts of rabbit brain, 
thymus and human and pig lymphocytes [22]. We 
attempted to demonstrate this enzyme in extracts 
of rat brain as well. Exactly as in our previous 
experiments the phosphol ipid-dependent but 
Ca2+-inhibited protein kinase was present in the 
extracts of some brains (fig.2) but not detectable in 
others (fig.la). When present in the extract, elu- 
t ion from the hydroxyapatite column occurred be- 
tween type II and II I  isoenzymes (fig.2). In every 
case where this Ca2+-inhibited enzyme was ob- 
served, a relatively high peptide kinase activity 
apparently independent of Ca 2+ and phospholipid 
was also present in the extract. This peptide kinase 
activity was strongly inhibited by phosphati- 
dylserine (see the overlapping leading edge of 
the phosphatidylserine-dependent Ca2+-inhibited 
peak), suggesting that it was a degradation product 
of protein kinase C. Type III protein kinase C was 
always absolutely CaE+/phospholipid dependent. 
The oligopeptide Ala-Ala-Ala-Ser-Phe-Lys-Ala- 
Lys-Lys-amide used here contains the -Ser-Phe- 
Lys- sequence found at the phosphorylat ion site of 
histone H1 [23,24] and two addit ional basic 
residues at the C-terminal side of Ser. Pep-e, used 
for detection of the activity of PKC-e, includes the 
sequence -Ser-Val-Arg-Arg-Arg-. At least parts of 
the specificity determinants of the two synthetic 
peptides seem to be similar. Therefore, it is con- 
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Fig.1. High-performance hydroxyapatite chromatographic 
pattern of protein kinase C isoenzymes of the crude extract of 
brain. Data obtained for extracts from (A) rat brain and (B) 
rabbit brain. Phosphotransferase activity was measured with 
the synthetic peptide as a substrate in the presence of: 0.5 mM 
EGTA (o---o),  0.5 mM CaC12 + 25/zg/ml phosphatidyl- 
serine + 50 ng/ml diacylglycerol (e, ;); 0.5 mM EGTA + 
25/~g/ml phosphatidylserine + 50 ng/ml diacylglycerol 
(x - -x ) .  
ceivable that the phospholipid-dependent protein 
kinase which does not need Ca 2+ for its activity, 
but behaves in quite the opposite way of being in- 
hibited by Ca 2+ is identical to PKC-e. However, we 
cannot exclude the possibility that it is only a 
degradation product of  some type of  protein 
kinase C. 
The histone H1 kinase and peptide kinase ac -  
tivities of  the isoenzymic fractions were compared 
in preparations purified on a DEAE-Sephacel col- 
umn (fig.3). In these preparations type I and II 
isoenzymes were resolved and both components of  
type III enzyme were observed. The synthetic pep- 
tide was apparently a better substrate than histone 
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Fig.2. Phospholipid-dependent Ca2+-inhibited protein kinase in 
the extract of rat brain. Phosphotransferase activity was 
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Fig.3. Hydroxyapatite chromatographic pattern of protein 
kinase C isoenzymes in a rat brain preparation purified partially 
on DEAE-cellulose. (Inset) Protein kinase C activity in the 
fractions eluting from a DEAE-Sephacel column. The hatched 
area shows fractions which were combined, diaiysed vs 1 mM 
potassium phosphate (pH 7.5) and a sample of which was 
applied to the hydroxyapatite column. Phosphotransferase 
activity was measured with the oligopeptide (;  c , ,o - -~)  or 
histone H1 (-" _,, ,x A) as substrates. Reaction mixture 
contained 0.5 mM EGTA (o-- -o,  ~. A) or 0.5 mM CaC12 + 
25/zg/ml phosphatidylserine + 50 ng/ml diacylglycerol 
(; ;,-~ _-). 
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ponents of type III enzyme differed significantly in 
their relative activities with the two substrates. 
These two subfractions were demonstrated clearly 
after purification on phenyl-Sepharose. The first 
protein kinase C fractions eluting from phenyl- 
Sepharose contained high peptide kinase activity 
accompanied by low histone kinase activity, the 
bulk of the latter being delayed (fig.4a). Fractions 
containing this relatively high peptide kinase ac- 
tivity were combined and analyzed by hydroxy- 
apatite chromatography (fig.4b). In the position of 
type III PKC, two histone kinase peaks eluted 
from the hydroxyapatite column. The first (IIIa) 
was accompanied by somewhat higher peptide 
kinase activity while the second (IIIb) coincided 
with a peptide kinase peak about 6-fold greater vs 
that of histone kinase. Type II protein kinase C 
was also present. The top fraction of the histone 
kinase peak eluted from phenyl-Sepharose was 
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(fig.4c). This fraction contained mainly type II 
protein kinase C and IIIa and b isoenzymes were 
completely absent. Since type IIIb PKC is eluted 
from phenyl-Sepharose before the bulk of histone 
kinase activity, this fraction may be lost during the 
course of purification if the activity of PKC is 
tested on the basis of the phosphorylation of 
histone H1. 
Comparing the chromatographic profiles of type 
II protein kinase C observed in different ex- 
periments (figs 3,4b,c), it is conceivable that two 
components with different substrate specificities 
are also present in this fraction. For one compo- 
nent, the peptide is obviously a better substrate 
than histone H1 while for the other this difference 
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Fig.4. Differentiation of type Ilia and IIIb subfractions of protein kinase C. (A) Phenyl-Sepharose chromatographic pattern of rat 
brain protein kinase C. (Inset) Activity of protein kinase C in fractions eluting from a DEAE-Sephacel column. The hatched area 
indicates fractions which were combined and applied to the phenyl-Sepharose column. A potassium phosphate concentration gradient 
was used from 0.75 to 0.005 M phosphate and finally (where indicated by an arrow) the column was washed with 0.0005 M potassium 
phosphate. Fractions 10, 11 (denoted by B) were combined, concentrated on a Centricon concentrator, diluted with 5 mM potassium 
phosphate and a sample was analyzed by hydroxyapatite chromatography (B). Fraction 14 (designated C) was treated similarly and 
was also analyzed by hydroxyapatite chromatography (C). Phosphotransferase activity was measured with the synthetic peptide or 
histone HI as substrates. Symbols as in fig.3. 
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does not appear to be significant. However, com- 
ponents of type II PKC have not been separated in 
our experiments. Nevertheless, the present results 
indicate that the synthetic oligopeptide substrate 
Ala-Ala-Ala-Ser-Phe-Lys-Ala-Lys-Lys-amide pro- 
vides a tool for detecting some subspecies of pro- 
tein kinase C which cannot be differentiated on the 
basis of histone kinase activity. 
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